SOW
LGND icon

State of Wyoming’s Ligand Pharmaceuticals LGND Stock Holding History

State of Wyoming’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-894
Closed -$169K – 1930
2025
Q4 		$169K Buy
+894
New +$172K 0.02% 1075
2024
Q1 		– Sell
-1,288
Closed -$92K – 1743
2023
Q4 		$92K Buy
+1,288
New +$76K 0.02% 1042
2023
Q2 		– Sell
-2,566
Closed -$189K – 1686
2023
Q1 		$189K Buy
2,566
+1,898
+284% +$135K 0.06% 366
2022
Q4 		$44.6K Buy
+668
New +$43.4K 0.01% 1105
2022
Q3 		– Sell
-183
Closed -$10K – 1747
2022
Q2 		$10K Sell
183
-397
-68% -$22.5K 0.01% 1642
2022
Q1 		$41K Sell
580
-289
-33% -$21K 0.02% 1166
2021
Q4 		$84K Buy
869
+289
+50% +$26.7K 0.04% 765
2021
Q3 		$50K Buy
580
+405
+231% +$31.3K 0.03% 756
2021
Q2 		$14K Buy
+175
New +$14.6K 0.01% 975

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

State of Wyoming's LGND Position: Q1 2026 in Review

State of Wyoming sold out of Ligand Pharmaceuticals (LGND) in Q1 2026, closing a stake of 894 shares — an estimated $169K sold.

State of Wyoming first reported a position in LGND in Q2 2021 and held it in 9 quarters. The position peaked at $189K in Q1 2023. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • State of Wyoming reported no remaining Ligand Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • State of Wyoming sold 894 Ligand Pharmaceuticals shares in Q1 2026, an estimated $169K.
  • State of Wyoming first reported a position in Ligand Pharmaceuticals in Q2 2021 and held it in 9 quarters.
  • State of Wyoming's Ligand Pharmaceuticals position peaked at $189K in Q1 2023.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.